• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problems Contamination (1120); Improper or Incorrect Procedure or Method (2017)
Patient Problem Peritonitis (2252)
Event Date 06/11/2014
Event Type  Injury  
Event Description
It was reported that a patient experienced a break in aseptic technique further described as the patient did not wash hands or clean the area before the start of peritoneal dialysis (pd) therapy, which caused peritonitis.On the same day as the onset, the patient was hospitalized for the peritonitis.The treatment was with vancomycin intraperitoneally (ip) (dose and frequency not reported), fortaz ip (dose and frequency not reported), gentamycin ip, (dose and frequency not reported) and cipro orally (dose and frequency not reported) for the peritonitis.The patient was discharged from the hospital after three days.At the time of this report, the patient was recovering from the peritonitis.The pd therapy was ongoing.The patient was retrained on aseptic technique.Additional information was requested but was not available at this time.
 
Manufacturer Narrative
(b)(4).On an unreported date in the same month as the onset of the peritonitis, the patient was completely recovered from the peritonitis event.Should additional relevant information become available, a follow up report will be submitted.
 
Manufacturer Narrative
(b)(4).As the sample was not returned and the lot number is unknown, a device analysis cannot be completed.This is a report of a use error that resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
Manufacturer Contact
christina arnt
25212 w. illinois route 120
round lake, IL 60073
2242703198
MDR Report Key3919646
MDR Text Key4515625
Report Number1416980-2014-21803
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 06/13/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/09/2014
Initial Date FDA Received07/08/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/01/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
DIANEAL 2.5% AMBUFLEX AND EXTRANEAL
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age40 YR
-
-